These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 24914042)

  • 1. In reply to the letter to the editor 'in Reply to Gandaglia et al.' by De Bari et al.
    Gandaglia G; Karakiewicz PI; Briganti A; Menon M; Sun M; Abdollah F
    Ann Oncol; 2014 Sep; 25(9):1862-1863. PubMed ID: 24914042
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Berardino De Bari, Stefano Arcangeli, and Filippo Alongi's letter to the editor re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur Urol 2014;65:546-51.
    Suardi N; Cozzarini C; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):e27-8. PubMed ID: 25281387
    [No Abstract]   [Full Text] [Related]  

  • 3. In reply to Gandaglia et al.
    De Bari B; Arcangeli S; Alongi F
    Ann Oncol; 2014 Sep; 25(9):1861-1862. PubMed ID: 24914043
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Berardino De Bari, Filippo Alongi, Stefano Arcangeli's letter to the editor re: Cesare Cozzarini, Claudio Fiorino, Chiara Deantoni, et al. Higher-than-expected severe (grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Eur urol 2014;66:1024-30.
    Cozzarini C; Fiorino C; Briganti A; Montorsi F; Di Muzio N
    Eur Urol; 2014 Dec; 66(6):e113-4. PubMed ID: 25199719
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to G. Gandaglia et al and K. Lu.
    Shumway DA; Hamstra DA
    J Clin Oncol; 2015 Sep; 33(25):2833-4. PubMed ID: 26215955
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to G. Gandaglia et al and K. Lu.
    Bekelman JE; Mitra N; Handorf EA; Uzzo RG; Hahn SM; Polsky D; Armstrong K
    J Clin Oncol; 2015 Sep; 33(25):2833. PubMed ID: 26215947
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Abdollah F; Montorsi F; Briganti A
    Eur Urol; 2015 Aug; 68(2):e37-8. PubMed ID: 25801052
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Michael Froehner, Manfred P. Wirth's letter to the editor re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
    Hu JC
    Eur Urol; 2014 Nov; 66(5):e86. PubMed ID: 24882671
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026.
    Gandaglia G; Sun M; Briganti A; Karakiewicz PI
    Eur Urol; 2014 Aug; 66(2):e36-7. PubMed ID: 24746970
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588-96.
    Freedland SJ; Den RB
    Eur Urol; 2016 Oct; 70(4):e110-e111. PubMed ID: 26992279
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 May; 73(5):e131-e132. PubMed ID: 29395499
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
    Bravi CA; Montorsi F; Briganti A
    Eur Urol; 2020 Dec; 78(6):e223-e224. PubMed ID: 33023772
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Stavrinides V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Oct; 78(4):e166. PubMed ID: 32712048
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Francesco Montorsi, Armando Stabile, Elio Mazzone, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Deepika Reddy, Max Peters, Taimur T. Shah, et al. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol 2022;81:407-13.
    Reddy D; Ahmed HU
    Eur Urol; 2022 Sep; 82(3):e74-e75. PubMed ID: 35690513
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 Feb; 73(2):e36-e37. PubMed ID: 28890246
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, João A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients: Rio de Janeiro is Still Beautiful.
    Ferreira Coelho R; Afonso de Carvalho P; Betoni Guglielmetti G; Dener Cordeiro M; Carlos Nahas W
    Eur Urol; 2021 Feb; 79(2):e47-e49. PubMed ID: 33162248
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, Joāo A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients.
    Patel V
    Eur Urol; 2021 Feb; 79(2):e50-e51. PubMed ID: 33334623
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
    Gandaglia G; Montorsi F; Briganti A
    Eur Urol; 2020 Nov; 78(5):e200. PubMed ID: 32800726
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all.
    Kasivisvanathan V; Takwoingi Y; Emberton M; Moore CM
    Eur Urol; 2019 Nov; 76(5):e133-e134. PubMed ID: 31400949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 60.